These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37688782)

  • 1. SLC9A2, suppressing by the transcription suppressor ETS1, restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis.
    Han J; Li S; Cao J; Han H; Lu B; Wen T; Bian W
    Environ Toxicol; 2024 Jan; 39(1):238-251. PubMed ID: 37688782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
    Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
    Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00704 contributes to the proliferation and accelerates the cell cycle of nasopharyngeal carcinoma cells via regulating ETS1/CDK6 axis.
    Wang Y; Tan QY; Shen Y; Liu CY; Huang T; Huai D; Dai J
    Kaohsiung J Med Sci; 2022 Apr; 38(4):312-320. PubMed ID: 34989116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches.
    Zhang Q; Zhu J; Xie J; Gu Y; Chen L
    PeerJ; 2024; 12():e17397. PubMed ID: 38784391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma.
    Yang C; Cao H; Yang JW; Wang JT; Yu MM; Wang BS
    Neoplasma; 2022 Jul; 69(4):841-858. PubMed ID: 35532293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
    Wang W; Wang B
    BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer.
    Zhang X; Wu D; Aldarouish M; Yin X; Li C; Wang C
    Int J Oncol; 2017 Jan; 50(1):232-240. PubMed ID: 27878249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. piR-39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma.
    Das B; Jain N; Mallick B
    Biol Cell; 2020 Mar; 112(3):73-91. PubMed ID: 31879982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
    PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis.
    Xiao Q; Wei Z; Li Y; Zhou X; Chen J; Wang T; Shao G; Zhang M; Zhang Z
    Oncol Rep; 2018 Jun; 39(6):2703-2710. PubMed ID: 29693191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
    Hu Y; Luo H; Zhu X; Guo H
    Comput Math Methods Med; 2021; 2021():7566365. PubMed ID: 34853603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
    Yan T; Zhu S; Zhang J; Lu G; Lv C; Wei Y; Luo M
    Mol Med Rep; 2018 Dec; 18(6):5221-5228. PubMed ID: 30280196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circHIPK3 promotes proliferation and migration and invasion via regulation of miR‑637/HDAC4 signaling in osteosarcoma cells.
    Wen Y; Li B; He M; Teng S; Sun Y; Wang G
    Oncol Rep; 2021 Jan; 45(1):169-179. PubMed ID: 33416147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
    Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
    Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.
    Hu R; Chen S; Yan J
    J Orthop Surg Res; 2021 May; 16(1):300. PubMed ID: 33962616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
    Bhattacharya R; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.